Chronic Lymphocytic Leukemia vs Jackson Heart Study

@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Chronic Lymphocytic Leukemia @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Chronic Lymphocytic Leukemia @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Chronic Lymphocytic Leukemia content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

The Jackson Heart Study (JHS) is the largest single-site community study of heart disease and its risk factors. While we focus on heart health, we also examine kidney disease, sleep, and social determinates of health among African Americans. JHS started with 5,306 African American men and women in the surrounding Jackson areas including Hinds, Madison, and Rankin Counties. JHS promotes heart health by engaging the community, training minority health professionals, educating the public and conducting research and sharing findings. The JHS will transform a history of African Americans’ heart disease into a legacy of heart health.